Assessing measurement invariance in the EORTC QLQ-C30.

Measurement invariance Medical oncology Palliative care Patient-reported outcomes Quality of life Validation studies

Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Mar 2022
Historique:
accepted: 24 07 2021
pubmed: 31 7 2021
medline: 17 3 2022
entrez: 30 7 2021
Statut: ppublish

Résumé

We aimed to investigate measurement invariance (MI) in the European Organisation for research and treatment of cancer quality of life questionnaire core 30 (EORTC QLQ-C30) in a heterogeneous sample of patients with cancer. Data from 12 studies within the PROFILES registry were used for secondary analyses (n = 7007). We tested MI by successive restrictions on thresholds, loadings, and intercepts across subgroups based on primary cancer sites, age, sex, time since diagnosis, and life stage, using multigroup confirmatory factor analysis (MGCFA) for ordered categorical measures. We also evaluated the impact of potentially miss-specified parameter equality across groups on latent factor means by releasing threshold and loading equality constraints for each item at a time. Results showed that the highest level of MI (invariance of thresholds, loadings, and intercepts) was found across groups based on time since diagnosis and life stage and to a lesser extent across groups based on sex, age, and primary tumor site. On item level, however, changes in the item's associated factor means were relatively small and in most cases canceled each other out to some extent. Given only a few instances of non-invariance in our study, there is reason to be confident that valid conclusions can be drawn from between-group comparisons of QLQ-C30 latent means as operationalized in our study. Nonetheless, further research into MI between other subgroups for the QLQ-C30 (i.e., treatment effects and ethnicity) is warranted. We stress the importance of including MI evaluations in the development and validation of measurement instruments.

Identifiants

pubmed: 34327634
doi: 10.1007/s11136-021-02961-8
pii: 10.1007/s11136-021-02961-8
pmc: PMC8921013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

889-901

Informations de copyright

© 2021. The Author(s).

Références

Qual Life Res. 2007 Feb;16(1):115-29
pubmed: 17109190
Qual Life Res. 2018 Apr;27(4):999-1014
pubmed: 29350345
Qual Life Res. 2009 Apr;18(3):381-8
pubmed: 19247808
Qual Life Res. 2012 Dec;21(10):1745-53
pubmed: 22193882
Acta Oncol. 2016 Jul;55(7):814-20
pubmed: 26882096
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Health Qual Life Outcomes. 2010 Jul 16;8:69
pubmed: 20637086
J Pain Symptom Manage. 2015 Mar;49(3):611-24
pubmed: 25135657
Qual Life Res. 2018 Aug;27(8):1937-1955
pubmed: 29427216
Eur J Cancer. 2011 Sep;47(14):2188-94
pubmed: 21621408
Educ Psychol Meas. 2016 Feb;76(1):114-140
pubmed: 29795859
Eur J Cancer. 2019 Nov;121:55-63
pubmed: 31561134
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Front Psychol. 2019 Oct 08;10:2147
pubmed: 31649573
Health Qual Life Outcomes. 2018 Jun 04;16(1):114
pubmed: 29866185
Psychometrika. 2016 Dec;81(4):1014-1045
pubmed: 27402166
Qual Life Res. 2015 Jan;24(1):125-33
pubmed: 25193618
Psychol Assess. 2002 Dec;14(4):439-50
pubmed: 12501569
Qual Life Res. 2006 Aug;15(6):1103-15; discussion 1117-20
pubmed: 16900290

Auteurs

Janneke van Roij (J)

The Netherlands Comprehensive Cancer Organisation, PO box 19079, Utrecht, 3501, DB, The Netherlands. j.vanroij@iknl.nl.
Department of Medical and Clinical Psychology, Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, Tilburg, the Netherlands. j.vanroij@iknl.nl.
Netherlands Association for Palliative Care (PZNL), Utrecht, The Netherlands. j.vanroij@iknl.nl.

Jacobien M Kieffer (JM)

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Lonneke van de Poll-Franse (L)

The Netherlands Comprehensive Cancer Organisation, PO box 19079, Utrecht, 3501, DB, The Netherlands.
Department of Medical and Clinical Psychology, Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, Tilburg, the Netherlands.
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Olga Husson (O)

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK.

Natasja J H Raijmakers (NJH)

The Netherlands Comprehensive Cancer Organisation, PO box 19079, Utrecht, 3501, DB, The Netherlands.
Netherlands Association for Palliative Care (PZNL), Utrecht, The Netherlands.

John Gelissen (J)

Department of Methodology and Statistics, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH